Design and tuning of ionic liquid–based HNO donor through intramolecular hydrogen bond for efficient inhibition of tumor growth

Developing ionic liquid (IL) drugs broaden new horizons in pharmaceuticals. The tunable nature endows ILs with capacity to delivery active ingredients. However, the tunability is limited to screen ionic components, and none realizes the kinetic tuning of drug release, which is a key challenge in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xiaoyu, Chen, Kaihong, Shi, Guiling, Lin, Wenjun, Bai, Hongzhen, Li, Haoran, Tang, Guping, Wang, Congmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673712/
https://www.ncbi.nlm.nih.gov/pubmed/33158861
http://dx.doi.org/10.1126/sciadv.abb7788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673712/
https://www.ncbi.nlm.nih.gov/pubmed/33158861
http://dx.doi.org/10.1126/sciadv.abb7788

Ejemplares similares